Trial Profile
Japan Unprotected Left Main Coronary artery Disease PCI Strategy On New Generation Stents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Cardiovascular disorders; Coronary artery disease
- Focus Therapeutic Use
- Acronyms J-LESSON
- 04 Mar 2019 Status changed from active, no longer recruiting to completed.
- 27 Dec 2018 Planned End Date changed from 1 May 2018 to 31 Jul 2018.
- 25 Sep 2018 Results of Serial IVUS Substudy assessing mini- mal MLA decrease, no chronic stent recoil, and few stent deformations after EES implantation, presented at the 30th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.